Sequence #5: Yes, Genomics Can Help With That

Published: July 13th 2018

Genomics is proving to be a game changer for many resource industries critical to Atlantic Canada’s economic growth. Nova Scotia’s Minister of Energy Geoff MacLellan recently announced details of his department’s $11.8-million commitment to Phase Two of Nova Scotia’s offshore growth […]

Read More


New offshore research funding announced

Published: June 26th 2018

“Combining genomics with geology has the potential to provide us with the clearest picture yet of petroleum deposits in Nova Scotia’s offshore.” Andy Stone, Director of Business Development, Genome Atlantic   The Nova Scotia Department of Energy recently announced a […]

Read More


Atlantic Canadian companies investing in genomics

Published: June 26th 2018

Business Expenditure on Research & Development (BERD) is an important indicator for economic growth.  Atlantic Canadian companies are investing significantly in genomics R&D, explains Genome Atlantic President & CEO Steve Armstrong, in a Letter published in The Telegram (St. John’s, […]

Read More

Request for Applications: New funding available for large-scale applied research in the agriculture and agri-food & fisheries and aquaculture sectors

Published: June 19th 2018

Friday, June 15, 2018 Ottawa, ON Today, Genome Canada, together with Agriculture and Agri-Food Canada (AAFC), is pleased to launch a Request for Applications for the 2018 Large-Scale Applied Research Project Competition: Genomics Solutions for Agriculture, Agri-Food, Fisheries and Aquaculture. The Competition […]

Read More

New Brunswick becoming world leader in cannabis sector

Published: May 24th 2018

Out of the gate, New Brunswick has positioned itself as a leader in the cannabis industry. With the legalization of recreational cannabis on the horizon in Canada, New Brunswick has identified cannabis as a major economic development driver and is […]

Read More

Genome Atlantic is part of the Innovation solution

Published: May 16th 2018

The Conference Board of Canada’s recently released Innovation Scorecard ranks most Canadian provinces low on Business Enterprise R&D. Genome Atlantic is part of the solution. Private sector investment makes up about ¼ of our R&D portfolio. Check out the Business Enterprise Expenditure […]

Read More


Sequence Issue #4: 163 lives saved….and counting

Published: May 4th 2018

Ten years ago, Newfoundland researchers cracked the genetic code of a cardiac disease that causes death in seemingly healthy young people. The disease, Type 5 ARVC, is particularly prevalent in Newfoundland and Labrador. Genome Atlantic recently caught up with researchers […]

Read More